| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6091acaeae510f9e12664ed6824b576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0887579603700b9811a8b4ea10f8c4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c580b241d9cc275189ce12337088988
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffa8f11e9a51f19716b6693105cd14d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07651f0b17227655c117890619885bc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_474c674403ec71e26742a650a427ba76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5632af890e5be06982aa2dec8cbe92ea |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-22084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-22082 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-22012 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-22 |
| filingDate |
2003-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83a4b93afcc8825a802be6af6c2f0640
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2712eaef9a4c3982ff94529a939c9367
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_148e342a1a70bfbcab7a5b43bc8fd4b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef72d9071ad4b10e12aa900b263e4c27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7efceb00c152a6ca5b68a98fe980b394
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6db05348e21cf5b06931d9ead617bd4e |
| publicationDate |
2004-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004096061-A1 |
| titleOfInvention |
Ultrasonic probe used with a pharmacological agent |
| abstract |
The present invention provides an apparatus and a method of using an ultrasonic probe (15) with a pharmacological agent to enhance an occlusion treating effect of the ultrasonic probe (15) to effectively remove an occlusion (16). The pharmacological agent is released through a catheter (36) to treat the occlusion (16) and enhance an effect of a transverse ultrasonic vibration of the ultrasonic probe (15) to effectively remove the occlusion (16). The pharmacological agent continues to travel downstream of the site of the occlusion (16) and work in conjunction with the ultrasonic probe (15) to reduce the occlusion (16) to a size that can easily be removed from the body naturally in order to provent reformation of the occlusion (16) and other health risks. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11035481-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9982791-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9775674-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10492865-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9360124-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013036732-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016081026-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023066200-A1 |
| priorityDate |
2003-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |